Using hospital wastewater to track antibiotic resistance
Part of Infections clinical trials.
This study looks at wastewater from a hospital to track antibiotic-resistant bacteria. By analyzing these samples, researchers hope to create an early warning system to improve infection control and protect patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must be a patient currently staying in the infectious diseases unit (SMIT) of Bichat hospital during a wastewater sampling period.
- You must agree to let your wastewater samples be used for this research.
- You cannot be under legal guardianship or similar protective measures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at bacteria (including antibiotic-resistant germs) present when you are admitted to a hospital. It may help doctors understand how often these germs are carried and how to respond early to prevent spread.
This trial tests whether a specific urine test result can help doctors safely avoid using strong, broad-spectrum antibiotics in patients with urinary tract infections. It aims to reduce unnecessary antibiotic use while still treating the infection effectively.
This study creates a bank of leftover blood and other samples from patients at two French hospitals. It helps researchers test new, faster ways to diagnose diseases.
This study looks at how antibiotic-resistant bacteria spread between people and their dogs in the same home. It aims to understand how these germs persist and change over time in humans, animals, and the environment.
This study looks at hospital wastewater to predict outbreaks of antibiotic-resistant bacteria. To take part, you must have a confirmed infection from such bacteria while in one of four specific hospital areas.
This trial looks at antibiotic resistance by testing wastewater in nursing homes. It aims to understand how resistance spreads and how to better protect residents.
Hear when a new Multidrug-resistant Organisms (MDROs) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.